Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6411 posts found.

astellas_main_web_2_0

Astellas investigated for ‘misleading’ PMCPA during ABPI code complaint

December 18, 2015 Medical Communications ABPI Code, Astellas, Astellas Pharma Europe, PMCPA, Prescription Medicines Code of Practice Authority

The Prescription Medicines Code of Practice Authority is investigating Astellas for deliberately providing an ‘incomplete and misleading’ response to a …
News

Prime Medical Group expands senior editorial team

December 17, 2015 Medical Communications Prime Medical Group

The Prime Medical Group has announced the appointment of Valerie Moss PhD to the position of editorial & scientific executive …
Appointment
FDA sign

FDA approves Lilly/Boehringer Lantus biosimilar

December 17, 2015 Medical Communications, Sales and Marketing Basaglar, Boehringer Ingelheim, Eli Lilly, Lantus, Sanofi, abasaglar, biosimilar, diabetes, insulin, lilly

The FDA has approved Eli Lilly and Boehringer Ingelheim’s long-acting insulin Basaglar (insulin glargine injection – a biosimilar to rival Sanofi’s …
News
ABPI code

Pharma company accused of ‘bribing’ prescribers slammed by PMCPA

December 17, 2015 Medical Communications ABPI Code, Daily Telegraph, PMCPA, Prescription Medicines Code of Practice Authority, Stirling Anglian

Stirling Anglian, the company at the centre of media criticism for arranging meetings at lavish hotels in an attempt to …
News
Shkreli KaloBios

Turing chief exec Martin Shkreli arrested

December 17, 2015 Medical Communications, Sales and Marketing Daraprim, FBI, Martin Shkreli, Shkreli, turing

Turing chief executive Martin Shkreli has been arrested on a charge of securities fraud relating to a company he founded, …
News
kelner_rob_070427

Valeant hires attorney and crisis management firm to handle bad US PR

December 17, 2015 Medical Communications, Sales and Marketing Robert Kelner, Valeant, Vianovo. Covington & Burling

Valeant has retained attorney Robert Kelner, a partner at the law firm Covington & Burling, to help the beleaguered pharma …
Appointment
jessica_fine

MSD UK appoints Jessica Fine as executive director of external affairs

December 16, 2015 Medical Communications Jessica Fine, MSD

MSD has appointed former Lexington Health boss Jessica Fine to lead its external affairs team in the UK from April …
Appointment
tony_gardiner

Avacta appoints Tony Gardiner as chief financial officer

December 16, 2015 Medical Communications Avacta Group

Avacta Group, the developer of Affimer biotherapeutics and research reagents, has appointed Tony Gardiner as group chief financial officer. Gardiner …
Appointment
juan_luciano

Juan Luciano appointed to Eli Lilly board

December 16, 2015 Medical Communications Eli Lilly

The board of directors of Eli Lilly has elected Juan Luciano as a new member, effective February 1 2016. Luciano …
Appointment

Precious Cells Group appoints David Huse in expansion push

December 15, 2015 Medical Communications, Research and Development Stem cells, precious cells group

Precious Cells Group, a UK-based international provider of stem cell storage and related technologies, has announced the appointment of commercial …
Appointment
personal-95715_640

Mirror. Signal. Merger. How to deal with a pharma takeover

December 14, 2015 Manufacturing and Production, Medical Communications, Sales and Marketing Deals, acquisition, buyouts, mergers, takeovers

So 2015 has been a record year for M&A in the pharma industry.The Financial Times has called this “the most …
Feature
Lynparza

NICE recommends AstraZeneca’s Lynparza after price reduction

December 11, 2015 Medical Communications, Sales and Marketing AstraZeneca, NICE, fallopian tube cancer, lynparza, olaparib, ovarian cancer, peritoneal cancer

NICE has recommended AstraZeneca’s Lynparza for maintenance treatment of relapsed ovarian, fallopian tube and peritoneal cancer. In draft guidance the …
News
roche_scientists

Which are pharma’s most innovative companies?

December 11, 2015 Medical Communications, Research and Development GSK, Roche, research and development

It has been a record-breaking year for the pharmaceutical industry in terms of deals, but what about the underlying innovation …
Feature
AZ_scientist

AstraZeneca deal to delve into the secretome

December 11, 2015 Medical Communications, Research and Development AstraZeneca, MedImmune, biologics, secretome

MedImmune, the biologics research and development arm of pharma giant AstraZeneca, has signed a collaboration with Swedish universities and research …
News

NICE publishes draft guidance on two prostate cancer treatments

December 11, 2015 Medical Communications, Research and Development, Sales and Marketing Astellas, Janssen, NICE, Xtandi, Zytiga, prostate cancer

NICE has issued final draft guidance recommending Astellas Pharma’s Xtandi (enzalutamide) in prostate cancer prior to chemotherapy, but not Janssen’s …
News
The Gateway to Local Adoption Series

Latest content

China approves fruquintinib combination for kidney cancer

May 29, 2026

BIOTRONIK, Charité and GHCF launch digital cardiology partnership

May 28, 2026

Endometriosis study begins recruitment in UK hospitals

May 28, 2026

MHRA authorises donidalorsen for hereditary angioedema prevention

May 27, 2026

Partnership aims to expand early access to medicines

May 26, 2026